Status:
COMPLETED
Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia
Lead Sponsor:
Janssen-Cilag, S.A.
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to establish and validate a scale/model that can be used to evaluate the duration of time and factors between short term hospital treatment and subsequent relapse periods ...
Detailed Description
This is an epidemiological (study of the distribution and determinants of health-related states or events in defined population), multicenter (study conducted at multiple sites), observational (study ...
Eligibility Criteria
Inclusion
- Patients with Schizophrenia or Schizoaffective disorder of more than 2 years evolution and who find themselves admitted in a Short-Term Psychiatric Hospitalization Unit or Acute Unit
Exclusion
- Other patients with a psychiatric pathology different to schizophrenia, schizoaffective/schizophreniform disorders
- Patients with schizophrenia or schizoaffective/schizophreniform disorders of 2 years, or less evolution
- Pregnant, lactating, or planning to become pregnant within the next 12 months
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
2339 Patients enrolled
Trial Details
Trial ID
NCT00358852
Start Date
August 1 2006
End Date
September 1 2008
Last Update
March 19 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.